Inhibitory effects of theophylline and procaterol on eosinophil function.

Eosinophils play a crucial role in bronchial asthma. As theophylline and procaterol (beta 2-agonist) are used for the treatment of bronchial asthma, the specific functions of eosinophils in the presence of granulocyte/macrophage colony-stimulating factor (GM-CSF) or platelet activating factor (PAF) were examined using theophylline and procaterol alone and in combination. Eosinophil degranulation induced by PAF or GM-CSF was inhibited by theophylline (10(-6) M-10(-3) M and 10(-6) M to 10(-3) M, respectively) and procaterol (10(-7) M-10(-5) M and 10(-7) M-10(-5) M, respectively). The combination of 10(-4) M theophylline and various concentrations of procaterol provided higher inhibition than 10(-4) M theophylline or procaterol (10(-7) M-10(-5) M). CD11b, which is a triggering molecule for human eosinophil degranulation, showed a significantly inhibited expression of PAF stimulation with 10(-4) M theophylline. CD11b and another triggering molecule for eosinophil degranulation, CD18, showed a significantly inhibited expression of PAF stimulation using a combination of 10(-4) M theophylline and various concentrations of procaterol (10(-5) M-10(-7) M) compared with the inhibition of 10(-4) M theophylline or procaterol (10(-5) M-10(-7) M), but GM-CSF-stimulated eosinophils were not inhibited. Taken collectively, theophylline and/or procaterol have anti-inflammatory effects.

[1]  M. Sekiguchi,et al.  Analysis of recombinant human tumour necrosis factor‐α‐induced CD4 expression on human eosinophils , 1996, Immunology.

[2]  C. Page,et al.  Theophylline and selective phosphodiesterase inhibitors as anti-inflammatory drugs in the treatment of bronchial asthma. , 1995, The European respiratory journal.

[3]  K. Chung,et al.  Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy. , 1995, American journal of respiratory and critical care medicine.

[4]  T. Honda,et al.  Adhesion molecules on eosinophils in acute eosinophilic pneumonia. , 1995, American journal of respiratory and critical care medicine.

[5]  A. Hatzelmann,et al.  Differential effects of non‐selective and selective phosphodiesterase inhibitors on human eosinophil functions , 1995, British journal of pharmacology.

[6]  P. Barnes,et al.  Cytokines as mediators of chronic asthma. , 1994, American journal of respiratory and critical care medicine.

[7]  R. Schleimer,et al.  The role of adhesion molecules in human eosinophil and basophil recruitment. , 1994, The Journal of allergy and clinical immunology.

[8]  H. Kita,et al.  CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor. , 1994, Journal of immunology.

[9]  C. Page,et al.  Anti-inflammatory effects of low-dose oral theophylline in atopic asthma , 1994, The Lancet.

[10]  S. Holgate,et al.  The 1992 Cournand Lecture. Asthma: past, present and future. , 1993, The European respiratory journal.

[11]  S. Durham,et al.  Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. , 1993, The Journal of allergy and clinical immunology.

[12]  J. Pober,et al.  Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1. , 1993, Journal of immunology.

[13]  R. Braun,et al.  Increased expression of CD11b and functional changes in eosinophils after migration across endothelial cell monolayers. , 1993, Journal of immunology.

[14]  J. Krutmann,et al.  Induction of intercellular adhesion molecule 1 (ICAM-1) expression in normal human eosinophils by inflammatory cytokines. , 1993, The Journal of investigative dermatology.

[15]  R. Braun,et al.  Induction and function of eosinophil intercellular adhesion molecule-1 and HLA-DR. , 1992, Journal of immunology.

[16]  S. Durham,et al.  Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. , 1991, The Journal of allergy and clinical immunology.

[17]  B. Undem,et al.  Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. , 1991, Thorax.

[18]  W. Calhoun,et al.  Modulation of superoxide production of alveolar macrophages and peripheral blood mononuclear cells by beta-agonists and theophylline. , 1991, The Journal of laboratory and clinical medicine.

[19]  H. Kita,et al.  Regulation of Ig-induced eosinophil degranulation by adenosine 3',5'-cyclic monophosphate. , 1991, Journal of immunology.

[20]  P. Barnes,et al.  Characterization of eosinophil cell activation by peptides. Differential effects of substance P, melittin, and FMET-Leu-Phe. , 1990, Journal of immunology.

[21]  K. Chung,et al.  Effect of theophylline and adenosine on eosinophil function. , 1989, The American review of respiratory disease.

[22]  N. Flavahan,et al.  The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity. , 1988, The Journal of allergy and clinical immunology.

[23]  Y. Arai,et al.  [Evaluation of procaterol aerosol as an aerosolized beta 2-adrenergic bronchodilator in conscious guinea pigs]. , 1985, Arerugi = [Allergy].

[24]  M. Badier,et al.  Spontaneous and provoked resistance to isoproterenol in isolated human bronchi. , 1984, The Journal of allergy and clinical immunology.

[25]  B. Petersson.  Sustained Inhibition of Antigen‐Induced Histamine Release from Human Lung by the β2‐Adrenoceptor Agonist Terbutaline , 1984, Allergy.

[26]  P. Meredith,et al.  Theophylline-salbutamol interaction: bronchodilator response to salbutamol at maximally effective plasma theophylline concentrations. , 1981, British journal of clinical pharmacology.

[27]  A. Leff,et al.  Beta adrenergic modulation of formyl-methionine-leucine-phenylalanine-stimulated secretion of eosinophil peroxidase and leukotriene C4. , 1994, The Journal of pharmacology and experimental therapeutics.

[28]  R. Townley,et al.  Inhibitory effects of formoterol on platelet-activating factor induced eosinophil chemotaxis and degranulation. , 1993, International archives of allergy and immunology.

[29]  R. Louis,et al.  Substance P-induced histamine release from human basophils, skin and lung fragments: effect of nedocromil sodium and theophylline. , 1990, International archives of allergy and applied immunology.

[30]  Phillips Yy,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. , 1987, The American review of respiratory disease.